Cargando…

Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve

BACKGROUND: The balloon-expandable SAPIEN 3 (S3) is superior to the older-generation balloon-expandable SAPIEN XT (XT) in a lower incidence of paravalvular aortic regurgitation, lower complication rates and better survival in transcatheter aortic valve implantation (TAVI). However, prosthesis–patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyasaka, Masaki, Tada, Norio, Taguri, Masataka, Kato, Shigeaki, Enta, Yusuke, Hata, Masaki, Watanabe, Yusuke, Naganuma, Toru, Yamawaki, Masahiro, Yamanaka, Futoshi, Shirai, Shinichi, Ueno, Hiroshi, Mizutani, Kazuki, Tabata, Minoru, Takagi, Kensuke, Yamamoto, Masanori, Hayashida, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978259/
https://www.ncbi.nlm.nih.gov/pubmed/33737333
http://dx.doi.org/10.1136/openhrt-2020-001531
_version_ 1783667173874466816
author Miyasaka, Masaki
Tada, Norio
Taguri, Masataka
Kato, Shigeaki
Enta, Yusuke
Hata, Masaki
Watanabe, Yusuke
Naganuma, Toru
Yamawaki, Masahiro
Yamanaka, Futoshi
Shirai, Shinichi
Ueno, Hiroshi
Mizutani, Kazuki
Tabata, Minoru
Takagi, Kensuke
Yamamoto, Masanori
Hayashida, Kentaro
author_facet Miyasaka, Masaki
Tada, Norio
Taguri, Masataka
Kato, Shigeaki
Enta, Yusuke
Hata, Masaki
Watanabe, Yusuke
Naganuma, Toru
Yamawaki, Masahiro
Yamanaka, Futoshi
Shirai, Shinichi
Ueno, Hiroshi
Mizutani, Kazuki
Tabata, Minoru
Takagi, Kensuke
Yamamoto, Masanori
Hayashida, Kentaro
author_sort Miyasaka, Masaki
collection PubMed
description BACKGROUND: The balloon-expandable SAPIEN 3 (S3) is superior to the older-generation balloon-expandable SAPIEN XT (XT) in a lower incidence of paravalvular aortic regurgitation, lower complication rates and better survival in transcatheter aortic valve implantation (TAVI). However, prosthesis–patient mismatch (PPM) more frequently occurs in S3 than XT. Further, little information is available on PPM after TAVI using S3 in Asians. This study aims to determine the incidence and predictors of PPM in S3 by focusing on the difference between S3 and XT using data from a Japanese multicentre registry. METHODS: From the Optimised transCathEter vAlvular iNtervention-TAVI (OCEAN-TAVI) registry, 2134 patients undergoing TAVI using S3 or XT were included. PPM was defined as moderate if ≧0.65 but ≦0.85 cm(2)/m(2) or severe if <0.65 cm(2)/m(2) at the indexed effective orifice area by postprocedural echocardiography. RESULTS: The incidence of moderate and severe PPM in S3 was 13.3% and 1.3%, respectively. The 20 mm transcatheter heart valve (THV) was more frequently used in S3 than XT (7.4% vs 2.4%, p<0.0001). PPM was more frequently observed in S3 than XT (14.7% vs 8.8%, p<0.0001). Multivariate logistic regression analysis revealed S3 predicted PPM (OR 1.92 (95% CI 1.35 to 2.74), p=0.0003). The mutual predictors for PPM between S3 and XT were younger age, larger body surface area, smaller aortic valve area, no balloon postdilatation and the use of 20 mm and 23 mm THV. When comparing 23 mm, 26 mm and 29 mm S3, the ORs of 20 mm S3 were 5.67 (95% CI 2.88 to 11.12), 19.24 (95% CI 8.13 to 46.86) and 51.03 (95% CI 12.28 to 280.77), respectively. CONCLUSIONS: The incidence of PPM after TAVI using S3 was 14.6% overall in this Asian population. PPM was more frequently observed in S3 than XT. A considerable number of patients were treated by the 20 mm S3 in an Asian cohort. The 20 mm THV was identified as a strong predictor for PPM.
format Online
Article
Text
id pubmed-7978259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-79782592021-03-30 Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve Miyasaka, Masaki Tada, Norio Taguri, Masataka Kato, Shigeaki Enta, Yusuke Hata, Masaki Watanabe, Yusuke Naganuma, Toru Yamawaki, Masahiro Yamanaka, Futoshi Shirai, Shinichi Ueno, Hiroshi Mizutani, Kazuki Tabata, Minoru Takagi, Kensuke Yamamoto, Masanori Hayashida, Kentaro Open Heart Valvular Heart Disease BACKGROUND: The balloon-expandable SAPIEN 3 (S3) is superior to the older-generation balloon-expandable SAPIEN XT (XT) in a lower incidence of paravalvular aortic regurgitation, lower complication rates and better survival in transcatheter aortic valve implantation (TAVI). However, prosthesis–patient mismatch (PPM) more frequently occurs in S3 than XT. Further, little information is available on PPM after TAVI using S3 in Asians. This study aims to determine the incidence and predictors of PPM in S3 by focusing on the difference between S3 and XT using data from a Japanese multicentre registry. METHODS: From the Optimised transCathEter vAlvular iNtervention-TAVI (OCEAN-TAVI) registry, 2134 patients undergoing TAVI using S3 or XT were included. PPM was defined as moderate if ≧0.65 but ≦0.85 cm(2)/m(2) or severe if <0.65 cm(2)/m(2) at the indexed effective orifice area by postprocedural echocardiography. RESULTS: The incidence of moderate and severe PPM in S3 was 13.3% and 1.3%, respectively. The 20 mm transcatheter heart valve (THV) was more frequently used in S3 than XT (7.4% vs 2.4%, p<0.0001). PPM was more frequently observed in S3 than XT (14.7% vs 8.8%, p<0.0001). Multivariate logistic regression analysis revealed S3 predicted PPM (OR 1.92 (95% CI 1.35 to 2.74), p=0.0003). The mutual predictors for PPM between S3 and XT were younger age, larger body surface area, smaller aortic valve area, no balloon postdilatation and the use of 20 mm and 23 mm THV. When comparing 23 mm, 26 mm and 29 mm S3, the ORs of 20 mm S3 were 5.67 (95% CI 2.88 to 11.12), 19.24 (95% CI 8.13 to 46.86) and 51.03 (95% CI 12.28 to 280.77), respectively. CONCLUSIONS: The incidence of PPM after TAVI using S3 was 14.6% overall in this Asian population. PPM was more frequently observed in S3 than XT. A considerable number of patients were treated by the 20 mm S3 in an Asian cohort. The 20 mm THV was identified as a strong predictor for PPM. BMJ Publishing Group 2021-03-18 /pmc/articles/PMC7978259/ /pubmed/33737333 http://dx.doi.org/10.1136/openhrt-2020-001531 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Valvular Heart Disease
Miyasaka, Masaki
Tada, Norio
Taguri, Masataka
Kato, Shigeaki
Enta, Yusuke
Hata, Masaki
Watanabe, Yusuke
Naganuma, Toru
Yamawaki, Masahiro
Yamanaka, Futoshi
Shirai, Shinichi
Ueno, Hiroshi
Mizutani, Kazuki
Tabata, Minoru
Takagi, Kensuke
Yamamoto, Masanori
Hayashida, Kentaro
Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
title Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
title_full Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
title_fullStr Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
title_full_unstemmed Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
title_short Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
title_sort incidence and predictors of prosthesis–patient mismatch after tavi using sapien 3 in asian: differences between the newer and older balloon-expandable valve
topic Valvular Heart Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978259/
https://www.ncbi.nlm.nih.gov/pubmed/33737333
http://dx.doi.org/10.1136/openhrt-2020-001531
work_keys_str_mv AT miyasakamasaki incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT tadanorio incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT tagurimasataka incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT katoshigeaki incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT entayusuke incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT hatamasaki incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT watanabeyusuke incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT naganumatoru incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT yamawakimasahiro incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT yamanakafutoshi incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT shiraishinichi incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT uenohiroshi incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT mizutanikazuki incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT tabataminoru incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT takagikensuke incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT yamamotomasanori incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT hayashidakentaro incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve
AT incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve